Skip to Content
Shadow

Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla®
PRINCETON, N.J. , May 17, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it has resubmitted to the U.S. Food and Drug Administration ( FDA ) the NDA for its lead product candidate, Twirla ® , an investigational low-dose combined...
Toggle Summary Agile Therapeutics Secures Debt Facility From Hercules Technology Growth Capital of Up to $25.0 Million and Provides Update on Status of Clinical Trial
PRINCETON, N.J. , Feb. 24, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced today that it has entered into a loan and security...
Toggle Summary Agile Therapeutics Strengthens Commercial Leadership Team
PRINCETON, N.J. , Jan. 02, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the appointment of Kimberly Whelan as Vice President of Market Access. Ms. Whelan has over 35 years of experience in the healthcare industry working in finance,...
Toggle Summary Agile Therapeutics Strengthens Executive Leadership Team with New Chief Commercial Officer
Appoints Former Senior J&J Executive responsible for leading launch of ORTHO EVRA®...
Toggle Summary Agile Therapeutics Strengthens Executive Leadership Team with the Appointment of Paul Korner, MD, MBA, as Chief Medical Officer
PRINCETON, N.J. , Aug. 17, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced the appointment of Paul Korner , MD, MBA, to the position of Chief Medical Officer. Dr. Korner is a board-certified obstetrician and...
Toggle Summary Agile Therapeutics to Host First Analyst Day on October 10, 2017
PRINCETON, N.J., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced that the Company will host its first Analyst Day on Tuesday, October 10, 2017 in New York City. Members of Agile's executive team will review clinical data and...
Toggle Summary Agile Therapeutics to Host First Quarter 2020 Financial Results and Business Update Conference Call on Tuesday, May 5, 2020
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J. , April 23, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced it will report first quarter 2020 financial results after the market close on Tuesday, May 5,...
Toggle Summary Agile Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Monday, March 1, 2021
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J. , Feb. 19, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2020 financial results after the market close on Monday, March 1,...
Toggle Summary Agile Therapeutics to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Wednesday, March 30, 2022
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., March 07, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2021 financial results after the market close on Wednesday, March...
Toggle Summary Agile Therapeutics to Host Second Quarter 2020 Financial Results and Business Update Conference Call on Tuesday, August 11, 2020
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J. , July 21, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced it will report second quarter 2020 financial results after the market close on Tuesday, August...
Shadow